期刊文献+

十二指肠乳头神经内分泌瘤3例报告 被引量:1

Neuroendocrine tumor of duodenal papilla: a clinical analysis of 3 cases
下载PDF
导出
摘要 目的探讨十二指肠乳头神经内分泌瘤的临床病理学特征、诊断及治疗方法。方法回顾性分析3例十二指肠乳头神经内分泌瘤患者的临床资料,男性2例,女性1例,发病年龄68、66和52岁;主要临床表现分别为上腹痛,腹泻及消化道出血;行影像学检查提示2例十二指肠降部占位,3例胃十二指肠镜检示十二指肠乳头病变,活检病理为神经内分泌瘤。3例均行胰十二指肠切除术(PD术),分析患者术后临床病理特征及预后。结果术后病理发现2例为十二指肠乳头神经内分泌肿瘤G1级,1例为G2级。3例患者均得到随访,1例术后7个月仍无瘤生存,1例术后生存>5年,1例术后4年8个月死于复发。结论十二指肠乳头神经内分泌瘤临床较罕见,无特异性临床表现,术前十二指肠镜检有助于明确诊断,积极的手术治疗是主要的治疗方式。 Objective To study the clinicopathological features, diagnosis and surgical treatment of duodenal papilla neu-roendocrine tumors ( DPNETs) .Methods Clinical data of 3 DPNET patients and their surgical treatment outcome were ret-rospectively analyzed with related literatures reviewed.The patients were 68,66 and 52 years old.Main clinical symptoms included abdominal pain, diarrhea and upper gastrointestinal bleeding.Imaging studies of 2 cases revealed mass lesions in the descending part of duodenum.Esophagogastroduodenoscopy ( EGD) of the 3 cases indicated duodenal papilla lesions. Biopsies demonstrated neuroendocrine tumors by pathology. Results All patients underwent pancreaticoduodenectomy ( PD) .Pathological reports were G1 grade in 2 cases and G2 grade in 1 case.The patients were followed up after opera-tion.Of the 3 patients, two patients survived while the other patient died due to recurrence after 4 years and 8 months of surgery.Conclusion Duodenal papilla neuroendocrine tumor is relatively rare and does not have specific clinical manifesta-tions.Preoperative EGD is helpful for diagnosis.Surgical resection is the mainstay of treatment.
出处 《大连医科大学学报》 CAS 2015年第6期560-563,共4页 Journal of Dalian Medical University
基金 国家自然科学基金项目(81273922)
关键词 十二指肠 神经内分泌瘤 诊断 手术 duodenum neuroendocrine carcinoma diagnosis operation
  • 相关文献

参考文献5

二级参考文献35

  • 1Eswaran Selvakumar,Shanmugasundaram Rajendran,Tirupporur Govindaswamy Balachandar,Devy Gounder Kannan,Satyanesan Jeswanth,Palaniappan Ravichandran,Rajagopal Surendran.Neuroendocrine carcinoma of the ampulla of Vater:a clinicopathologic evaluation[J].Hepatobiliary & Pancreatic Diseases International,2008,7(4):422-425. 被引量:7
  • 2Yaov JC,Hassan M,Phan A,et al.One hundred years after "carcinoid ":epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.J Clin Oncol,2008,26(18):3063-3072.
  • 3Yao JC,Shah MH,Ito T,et al.Everolimus for advanced pancreatic neuroendocrine tumors.N Engl J Med,2011,364(6):514-523.
  • 4Raymond E,Dahan L,Raoul JL,et al.Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.N Engl J Med,2011,36(6):501-513.
  • 5Kl(o)ppel G,Couvelard A,Perren A,et al.ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors:towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.Neuroendocrinology,2009,90 (2):162-166.
  • 6Klimstra DS,Modlin IR,Adsay NV,et al.Pathology reporting of neuroendocrine tumors:application of the Delphic consensus process to the development of a minimum pathology data set.Am J Surg Pathol,2010,34(3):300-313.
  • 7Bosman FT,Carneiro F,Hruban RH,et al.WHO classification of tumours of the digestive system.Lyon:IARC Press,2010.
  • 8Oberndorfer S.Karzinoide tumoren des dunndarms.Frankf ZPatrol,1907,1:426-432.
  • 9Williams ED,Siebenmann RE,Sobin LH.Histological typing of endocrine tumours.Geneva:World Health Organization,1980.
  • 10Hamilton SR,Aaltonen LA.World Health Organization classification of tumours.Pathology and genetics of tumours of the digestive system.Lyon:IARC Press,2000.

共引文献299

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部